In the June 10 issue of The ASCO Post, the article, “Study Questions Routine Use of Imaging after Treatment for Diffuse Large B-cell Lymphoma,” includes an error in an Expert Point of View box featuring an interview with Andrew D. Zelenetz, MD, PhD. Dr. Zelenetz is quoted as saying that at his institution (Memorial Sloan-Kettering Cancer Center), “80% of [diffuse large B-cell lymphoma] relapses are detected by scans.” He actually said that “80% of relapses are detected clinically and 20% by scans.”
We regret the error. A corrected version of the article can be found on ASCOPost.com. ■
